The Global Respiratory Monitoring Devices Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Global Respiratory Monitoring Devices Market is estimated to be USD 18.22 billion in 2018 and predicted to rise to USD 28.95 billion by 2023 with a CAGR of 9.7 %. The market is segmented by Type (Diagnostic Devices (spirometers, Peak flow meters) and Monitoring Devices (sleep test devices, gas analyzers, pulse oximeters, and capnograph)) and by region – Global Industry Analysis, Size, Share, Growth, Trends, and forecasts (2016-2021). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
Respiratory Monitoring Devices are used to measure the amount of air we inhale or exhale, Amount of oxygen present in blood or the Amount of carbon dioxide. There are many factors that are driving this market like increase in aging population, Prevalence of COPD Globally, rise in number of Smokers, Development of advanced Technology and rise in healthcare expenditure in emerging countries. But factors like huge price of Monitoring Devices and increased complexity are restraining the Market growth.
Pulse Oximeters dominate the market because of their accurate and fast results. Pulse oximeter is expected to be top segment for the coming years too because of its better diagnostic results compared to others.
North America dominates the Global market with a share of 37% and is expected to stay at the top for few more years. Availability to advanced Technology and presence of major players in this region are the main reasons for its highest share. Asia-Pacific is increasing at the highest CAGR because of increase in technological advancements and rise in disposable incomes.
Key players in this market are Covidien, GE Healthcare, Philips Healthcare, Siemens Healthcare, Resmed, Merck & Co. Inc, Calondo Pharmaceuticals Inc., Quark Pharmaceuticals Inc., Access Pharmaceuticals Inc., Sirnaomics Inc., and Traversa Therapeutics Inc.
Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-respiratory-monitoring-devices-system-market-1955/” and checkout our recent reports in the Medical Devices category at “http://www.marketdataforecast.com/research-reports/healthcare/medical-devices-2/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.